These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9506318)

  • 1. Inhibitory effect of azelastine hydrochloride and suplatast tosilate on airway responses in sensitized rats following exposure to antigen.
    Hanashiro K; Tamaki N; Koga T; Nakamura M; Kinjoh K; Kosugi T
    Int J Tissue React; 1997; 19(3-4):163-9. PubMed ID: 9506318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azelastine and suplatast shorten the distribution half-life of IgE in rats.
    Hanashiro K; Tokeshi Y; Nakasone T; Sunagawa M; Nakamura M; Kosugi T
    Mediators Inflamm; 2002 Feb; 11(1):61-4. PubMed ID: 11926596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice.
    Shim JJ; Dabbagh K; Takeyama K; Burgel PR; Dao-Pick TP; Ueki IF; Nadel JA
    J Allergy Clin Immunol; 2000 Apr; 105(4):739-45. PubMed ID: 10756224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
    Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs.
    Iijima H; Tamura G; Hsiue TR; Liu Y; Taniguchi H; Shirato K
    Am J Respir Crit Care Med; 1999 Jul; 160(1):331-5. PubMed ID: 10390420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
    Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
    Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
    Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
    Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
    Asano K; Mizutani T; Shimane T; Hisano M; Hisamitsu T; Suzaki H
    Mediators Inflamm; 2000; 9(2):77-84. PubMed ID: 10958380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of suplatast tosilate on eosinophil migration].
    Kobayashi Y; Nagata M; Yamamoto H; Sakamoto Y
    Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
    Kimata H
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma.
    Hoshino M; Fujita Y; Saji J; Inoue T; Nakagawa T; Miyazawa T
    Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
    Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
    Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigen-induced airway hyperresponsiveness in infantile guinea pigs].
    Taniguchi H; Tamura G; Iijima H; Liu Y; Shirato K
    Arerugi; 1998 Aug; 47(8):720-5. PubMed ID: 9796112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity.
    Satoh T; Sasaki G; Wu MH; Yokozeki H; Katayama I; Nishioka K
    Clin Immunol; 2003 Sep; 108(3):257-62. PubMed ID: 14499249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.
    Kurokawa M; Kawazu K; Asano K; Fumio K; Mita A; Adachi M
    Mediators Inflamm; 2001 Dec; 10(6):333-7. PubMed ID: 11817674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study.
    Yoshihara S; Fukuda H; Arisaka O
    Arzneimittelforschung; 2011; 61(7):421-4. PubMed ID: 21899211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suplatast tosilate, a new type of antiallergic agent, prevents the expression of airway hyperresponsiveness in guinea pigs.
    Taniguchi H; Togawa M; Ohwada K; Kiniwa M; Matsuura N; Nagai H; Koda A
    Eur J Pharmacol; 1996 Dec; 318(2-3):447-54. PubMed ID: 9016937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
    Konno S; Asano K; Gonokami Y; Kurokawa M; Kawazu K; Adachi M
    Arerugi; 1995 May; 44(5):556-61. PubMed ID: 7619009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
    Oda N; Minoguchi K; Tanaka A; Yokoe T; Minoguchi H; Matsuo H; Nakashima M; Tasaki T; Adachi M
    Clin Exp Allergy; 2002 Dec; 32(12):1782-6. PubMed ID: 12653172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiallergic activity of dimethyl-2-(phenylcarbamoyl)ethylsulfonium p-toluenesulfonate derivatives.
    Tada Y; Yamawaki I; Ueda S; Matsumoto H; Matsuura N; Yasumoto M; Koda A; Hori M
    J Med Chem; 1998 Aug; 41(18):3330-6. PubMed ID: 9719585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.